Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3917 Target Snapshot

Thyroid hormone receptor beta · SINGLE PROTEIN · Rattus norvegicus

104Compounds
31Assays
2Approved Drugs
74.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P18113. Use UniProt P18113 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P18113 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Thyroid hormone receptor beta as ChEMBL target CHEMBL3917, mapped to UniProt P18113. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Thyroid hormone receptor beta
SINGLE PROTEIN · Rattus norvegicus
As of 2026-09-14
ChEMBL target ID
CHEMBL3917
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P18113
Thyroid hormone receptor beta
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Thyroid hormone receptor beta is the right protein anchor across sources, using UniProt P18113 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelThyroid hormone receptor beta
UniProt AccessionP18113
Component TypeProtein
Sequence Length461 aa

Thyroid hormone receptor beta

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Thyroid hormone receptor beta, mapped to UniProt P18113. Sequence length is 461 aa.

Mapped IDP18113
Review nameThyroid hormone receptor beta
OrganismRattus norvegicus
Clinical Profile

Clinical Phase Distribution

2
Approved
1
Phase III
1
Phase II
Assay Mix

Activity Type Distribution

IC5074.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL163221 10.0 IC50 0.1 Preclinical
CHEMBL350265 10.0 IC50 0.1 Preclinical
CHEMBL289343 9.96 IC50 0.11 Preclinical
CHEMBL159682 9.85 IC50 0.14 Clinical
CHEMBL41632 9.82 IC50 0.15 Clinical
CHEMBL46882 9.72 IC50 0.19 Preclinical
CHEMBL350049 9.64 IC50 0.23 Preclinical
CHEMBL164421 9.59 IC50 0.26 Preclinical
CHEMBL163324 9.57 IC50 0.27 Preclinical
CHEMBL159976 9.51 IC50 0.31 Preclinical
Distribution

pChEMBL Value Distribution

1
5.0
2
5.5
7
6.0
2
6.5
9
7.0
3
7.5
7
8.0
7
8.5
6
9.0
10
9.5
pChEMBL
Approved Drugs

Approved Drugs

DEXTROTHYROXINE
CHEMBL559
Approved 1967
LIOTHYRONINE
CHEMBL1544
Approved 1956
Assay Landscape

Assay Landscape

31
Total Assays
52
Tested Compounds
2
Assay Types
Binding — 21 assays, 52 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 12 43 8.6
organism-based format 7 0
cell-free format 1 9 6.1
tissue-based format 1 0
Functional — 10 assays, 0 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 5 0
tissue-based format 4 0
organism-based format 1 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine